We are live on ! Find out more
SSIA

Spero-Smith Investment Advisers Portfolio holdings

AUM $74.5M
1-Year Est. Return 12.27%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+12.27%
3 Year Est. Return
+31.25%
5 Year Est. Return
10 Year Est. Return
AUM
$87.9M
AUM Growth
-$2.04M
Cap. Flow
-$1.61M
Cap. Flow %
-1.83%
Top 10 Hldgs %
43.14%
Holding
47
New
2
Increased
3
Reduced
33
Closed
1

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$814K
2
DD
Du Pont De Nemours E I
DD
+$252K
3
MCK icon
McKesson
MCK
+$216K
4
GE icon
GE Aerospace
GE
+$162K
5
FISV
Fiserv Inc
FISV
+$58.3K

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 19.93%
3 Energy 18.63%
4 Financials 11.61%
5 Communication Services 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XOM icon
1
ExxonMobil
XOM
$650B
$11.9M 13.59%
143,633
-330
-0.2% -$28.4K
DHR icon
2
Danaher
DHR
$138B
$3.34M 3.8%
58,051
-217
-0.4% -$12.4K
WFC icon
3
Wells Fargo
WFC
$254B
$3.02M 3.43%
53,604
-416
-0.8% -$23.2K
MCK icon
4
McKesson
MCK
$104B
$3.01M 3.42%
13,392
-935
-7% -$216K
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.11T
$2.94M 3.35%
110,920
-1,428
-1% -$38.3K
NVS icon
6
Novartis
NVS
$302B
$2.93M 3.34%
33,294
-223
-0.7% -$20.5K
FISV
7
Fiserv Inc
FISV
$29.7B
$2.81M 3.2%
67,978
-1,450
-2% -$58.3K
SHW icon
8
Sherwin-Williams
SHW
$83.5B
$2.78M 3.16%
30,291
-96
-0.3% -$9.1K
CVS icon
9
CVS Health
CVS
$135B
$2.59M 2.95%
24,699
-135
-0.5% -$13.8K
HBAN icon
10
Huntington Bancshares
HBAN
$34B
$2.57M 2.92%
226,861
-1,230
-0.5% -$13.8K
ACN icon
11
Accenture
ACN
$106B
$2.52M 2.87%
26,045
-269
-1% -$25.7K
VTRS icon
12
Viatris
VTRS
$20.8B
$2.51M 2.86%
37,052
-11,515
-24% -$814K
MSFT icon
13
Microsoft
MSFT
$2.9T
$2.36M 2.69%
53,494
-870
-2% -$39.7K
SRCL
14
DELISTED
Stericycle Inc
SRCL
$2.32M 2.63%
17,293
-142
-0.8% -$19.5K
CELG
15
DELISTED
Celgene Corp
CELG
$2.24M 2.55%
19,390
-110
-0.6% -$12.6K
BIIB icon
16
Biogen
BIIB
$30.9B
$2.23M 2.53%
5,516
-90
-2% -$36.1K
INTC icon
17
Intel
INTC
$413B
$2.07M 2.36%
68,177
-535
-0.8% -$17.3K
VZ icon
18
Verizon
VZ
$197B
$2.05M 2.33%
44,046
-190
-0.4% -$9.3K
CERN
19
DELISTED
Cerner Corp
CERN
$2.01M 2.28%
29,088
+85
+0.3% +$5.95K
SNI
20
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
$1.99M 2.26%
30,372
-340
-1% -$23.2K
ANSS
21
DELISTED
Ansys
ANSS
$1.98M 2.25%
21,695
-135
-0.6% -$12K
MET icon
22
MetLife
MET
$62.4B
$1.96M 2.23%
39,285
-11
-0% -$521
COP icon
23
ConocoPhillips
COP
$144B
$1.9M 2.16%
30,967
+29
+0.1% +$1.89K
EMC
24
DELISTED
EMC CORPORATION
EMC
$1.89M 2.15%
71,550
-640
-0.9% -$17.1K
TMO icon
25
Thermo Fisher Scientific
TMO
$214B
$1.88M 2.14%
14,485
-120
-0.8% -$15.6K

Similar funds

Spero-Smith Investment Advisers's Q2 2015 Portfolio in Review

As of Q2 2015, Spero-Smith Investment Advisers held 47 positions worth $87.9M, down 2.3% from $90M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Spero-Smith Investment Advisers's Q2 2015 filing shows 2 new, 3 increased, 33 reduced and 1 closed positions. Its largest new stake was Walgreens Boots Alliance: 2,584 shares worth $218K. The largest sale was Viatris, an estimated $814K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Technology and Energy.

  • Spero-Smith Investment Advisers's largest Q2 2015 buy was Walgreens Boots Alliance: 2,584 shares worth $218K.
  • Spero-Smith Investment Advisers added most to Cerner Corp in Q2 2015, an estimated $5.95K increase.
  • Spero-Smith Investment Advisers's biggest Q2 2015 reduction was Viatris, cutting an estimated $814K.
  • Spero-Smith Investment Advisers fully exited Du Pont De Nemours E I in Q2 2015, selling an estimated $252K.
  • Spero-Smith Investment Advisers's ten largest holdings make up 43% of its $87.9M portfolio in Q2 2015.
  • Spero-Smith Investment Advisers opened 2 new positions and closed 1 in Q2 2015.
  • Spero-Smith Investment Advisers's portfolio value fell 2.3% quarter-over-quarter to $87.9M.

Based on Spero-Smith Investment Advisers's 13F filing for Q2 2015, filed 30 Jul 2015.